CONTACT US
SIGN-IN
share
join us
profile
sign in
support us
contact us
29 May 2024

CALL FOR APPLICATIONS ADMISSION TO DOCTORAL PROGRAMMES – 40th cycle (AY 2024/25) at the University of Trieste

8 May 2024

The PhD students will be part of an interdisciplinary project combining live imaging, genetics, and computational approaches using C. elegans

24 April 2024

The laboratory directed by CNR researcher Dr. Marianna Leonzino in the "Area Neuro" of the Humanitas Research Hospital is seeking talented and highly motivated researchers at all career stages. Successful applicants will join a vibrant young team working on the role of interorganellar communication in neurodegenerative diseases and will contribute to a project aimed at dissecting cellular pathways leading to neuronal death in the context of Amyotrophic Lateral Sclerosis (ALS). The project is part of a collaborative effort involving also the lab of Dr. Paolo Colombi (IGM-CNR). The team uses human IPSC-derived neurons as a cellular model and takes advantage of gene-editing techniques to develop disease-modeling cell lines.

18 April 2024

PostDoc position at Istituto Italiano di Tecnologia – Animal studies For a project on the characterization of the safety profile of a drug in mice, we are seeking for a Post-Doc scientist to work at Istituto Italiano di Tecnologia, Genova, Italy. The project begins in September 2024 and it is expected to last 2-3 years. The selected candidate will perform all the animal activities envisaged for the project: animal handling and characterization at different life stages as well as behavioral studies. She/he will set up the appropriate in vivo behavioral models and study the pharmacokinetic biodistribution of the drug. Retribution and benefits are competitive and will be defined based on the Applicant’s experience.

9 April 2024

The laboratory of Prof. Santoro at Dept. of Biology, University of Padua and Venetian Institute Molecular Medicine (https://massimosantorolab.com) is seeking a PhD student to study endothelial signaling and metabolic pathways in Endo-MT-driven pathological angiogenesis.